midazolam and mdv 3100

midazolam has been researched along with mdv 3100 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Vries, M; Gibbons, JA; Krauwinkel, W; Mol, R; Mordenti, J; Noukens, J; Ohtsu, Y; Ouatas, T; van der Walt, JS	1
Hoffmann, M; Kumar, G; Narayanan, R; Surapaneni, S	1

Trials

1 trial(s) available for midazolam and mdv 3100

Article	Year
Pharmacokinetic Drug Interaction Studies with Enzalutamide. Clinical pharmacokinetics, 2015, Volume: 54, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Cross-Over Studies; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Male; Midazolam; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant	2015

Other Studies

1 other study(ies) available for midazolam and mdv 3100

Article	Year
Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide. Drug metabolism letters, 2016, Volume: 10, Issue:3 Topics: Adult; Antineoplastic Agents; Area Under Curve; Benzamides; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Male; Midazolam; Middle Aged; Models, Biological; Nitriles; Phenylthiohydantoin; Time Factors; Young Adult	2016

Article

Year

Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide.

Drug metabolism letters, 2016, Volume: 10, Issue:3

Topics: Adult; Antineoplastic Agents; Area Under Curve; Benzamides; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Male; Midazolam; Middle Aged; Models, Biological; Nitriles; Phenylthiohydantoin; Time Factors; Young Adult

2016